Annual Advancement in PRRS Research Award
At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts for PRRS control.
Despite years of hard work by scientists, researchers, practicing veterinarians, pork producers, animal health companies, and others, Porcine Reproductive and Respiratory Syndrome (PRRS) remains a costly, frustrating challenge to the global swine industry.
At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts for PRRS control.
Each year we issue a call for proposals for the Annual Boehringer Ingelheim Advancement in PRRS Research Award Program. The deadline for submissions are January 1 of each year.
Boehringer Ingelheim will provide three U.S. $25,000 awards to the winning proposals for PRRS research in the NAFTA region. Candidates included graduate students, academic researchers, company or private researchers, and practicing veterinarians.
The 2012 Advancement in PRRS Research Awards recipients will be announced at the American Association of Swine Veterinarians Conference in Denver, Colorado.
Objective: Examine practical methods of controlling, managing, and possibly eradicating the PRRS virus.
Once the three winning year-long research projects are completed and submitted for peer review, PRRB will conduct a second evaluation. Upon acceptance for publication of his or her findings, the first place award recipient will receive an additional U.S. $5,000; second place, $3,000; and third place, $1,000.
The independent PRRS Research Review Board (PRRB) members include:
- Tara Donovan, DVM, Hanor USA, Spring Green, Wisconsin
- Luc Dufresne, DVM, Seaboard Farms, Shawnee Mission, Kansas
- Tim Loula, DVM, Swine Vet Center, P.A., St. Peter, Minnesota
- Bill Mengeling, DVM, PhD, Diplo. ACVM, Iowa State University, Ames, Iowa
- Daryl Olsen, DVM, AMVC, Audubon, Iowa
- Montse Torremorell, DVM, PhD, University of Minnesota, Minneapolis, Minnesota
Proposals Due
The deadline for proposals for the 2012 Boehringer Ingelheim Vetmedica PRRS Research Award is:
January 1, 2012
Submit Your Proposal To:
-
The Advancement in PRRS Research Award
Boehringer Ingelheim Vetmedica, Inc.
Attn: Trudy Luther
5506 Corporate Dr., Suite 1600
St. Joseph, MO 64507-7752
About Boehringer Ingelheim Vetmedica
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
For Boehringer Ingelheim—and its employees—carrying a good share of social responsibility is an important component in its business culture. Both global commitments in social projects and properly caring for all its employees are included. Respect, equal opportunity, and the balance of career and family life form the basis for mutual cooperation. And, environmental protection and sustainability are always the main focus during any of Boehringer Ingelheim’s undertakings.
In 2010, Boehringer Ingelheim posted net sales of approximately $16.7 billion (about 12.6 billion euro) while spending almost 24% of net sales in its largest business segment, Prescription Medicines, on research and development.
For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.
Contact Us
-
The Advancement in PRRS Research Award
Boehringer Ingelheim Vetmedica, Inc.
Attn: Trudy Luther
5506 Corporate Dr., Suite 1600
St. Joseph, MO 64507-7752
